The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Pleural Effusion, Malignant

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Pleural Effusion, Malignant


High impact information on Pleural Effusion, Malignant


Chemical compound and disease context of Pleural Effusion, Malignant


Biological context of Pleural Effusion, Malignant


Anatomical context of Pleural Effusion, Malignant


Gene context of Pleural Effusion, Malignant


Analytical, diagnostic and therapeutic context of Pleural Effusion, Malignant


  1. Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies. Rusch, V.W., Niedzwiecki, D., Tao, Y., Menendez-Botet, C., Dnistrian, A., Kelsen, D., Saltz, L., Markman, M. J. Clin. Oncol. (1992) [Pubmed]
  2. Use of intracavitary cisplatin for the treatment of childhood solid tumors in the chest or abdominal cavity. Boyer, M.W., Moertel, C.L., Priest, J.R., Woods, W.G. J. Clin. Oncol. (1995) [Pubmed]
  3. Vascular endothelial growth factor levels and induction of permeability in malignant pleural effusions. Zebrowski, B.K., Yano, S., Liu, W., Shaheen, R.M., Hicklin, D.J., Putnam, J.B., Ellis, L.M. Clin. Cancer Res. (1999) [Pubmed]
  4. Characterization of a lung-cancer-associated auto-antigen. Zeng, C.Q., Alpert, L.C., Alpert, E. Int. J. Cancer (1992) [Pubmed]
  5. Intrapleural immunotherapy with Corynebacterium parvum in recurrent malignant pleural effusions. Millar, J.W., Hunter, A.M., Horne, N.W. Thorax (1980) [Pubmed]
  6. Elastance of the pleural space: a predictor for the outcome of pleurodesis in patients with malignant pleural effusion. Lan, R.S., Lo, S.K., Chuang, M.L., Yang, C.T., Tsao, T.C., Lee, C.H. Ann. Intern. Med. (1997) [Pubmed]
  7. Carcinoembryonic antigen levels in benign and malignant pleural effusions. Rittgers, R.A., Loewenstein, M.S., Feinerman, A.E., Kupchik, H.Z., Marcel, B.R., Koff, R.S., Zamcheck, N. Ann. Intern. Med. (1978) [Pubmed]
  8. Prospective randomized trial of intrapleural bleomycin versus interferon alfa-2b via ultrasound-guided small-bore chest tube in the palliative treatment of malignant pleural effusions. Sartori, S., Tassinari, D., Ceccotti, P., Tombesi, P., Nielsen, I., Trevisani, L., Abbasciano, V. J. Clin. Oncol. (2004) [Pubmed]
  9. Telomerase activity in pleural effusions: diagnostic significance. Yang, C.T., Lee, M.H., Lan, R.S., Chen, J.K. J. Clin. Oncol. (1998) [Pubmed]
  10. Intrapleural cisplatin and cytarabine in the management of malignant pleural effusions: a Lung Cancer Study Group trial. Rusch, V.W., Figlin, R., Godwin, D., Piantadosi, S. J. Clin. Oncol. (1991) [Pubmed]
  11. Retroviral gene transfer is inhibited by chondroitin sulfate proteoglycans/glycosaminoglycans in malignant pleural effusions. Batra, R.K., Olsen, J.C., Hoganson, D.K., Caterson, B., Boucher, R.C. J. Biol. Chem. (1997) [Pubmed]
  12. Phase I study of intrapleural batimastat (BB-94), a matrix metalloproteinase inhibitor, in the treatment of malignant pleural effusions. Macaulay, V.M., O'Byrne, K.J., Saunders, M.P., Braybrooke, J.P., Long, L., Gleeson, F., Mason, C.S., Harris, A.L., Brown, P., Talbot, D.C. Clin. Cancer Res. (1999) [Pubmed]
  13. Intrapleural palliative treatment of malignant pleural effusions with mitoxantrone versus placebo (pleural tube alone). Groth, G., Gatzemeier, U., Häussingen, K., Heckmayr, M., Magnussen, H., Neuhauss, R., Pavel, J.V. Ann. Oncol. (1991) [Pubmed]
  14. Application of mucin quantitative competitive reverse transcription polymerase chain reaction in assisting the diagnosis of malignant pleural effusion. Yu, C.J., Shew, J.Y., Liaw, Y.S., Kuo, S.H., Luh, K.T., Yang, P.C. Am. J. Respir. Crit. Care Med. (2001) [Pubmed]
  15. Pleural fluid pH: diagnostic, therapeutic, and prognostic value. Houston, M.C. Am. J. Surg. (1987) [Pubmed]
  16. Insulin-like growth factors and their binding proteins in pleural fluid. Le Bouc, Y., Bellocq, A., Philippe, C., Perin, L., Garabedian, M., Fouqueray, B., Zacharias, C., Cadranel, J., Baud, L. Eur. J. Endocrinol. (1997) [Pubmed]
  17. Elevation of interleukin-10 levels in malignant pleural effusion. Chen, Y.M., Yang, W.K., Whang-Peng, J., Kuo, B.I., Perng, R.P. Chest (1996) [Pubmed]
  18. Thoracotomy in the management of metastatic soft-tissue sarcomas in adults. Rosen, G., Holmes, E.C., Forscher, C.A., Lowenbraun, S., Eilber, F.R., Eckardt, J.J. Chest Surg. Clin. N. Am. (1994) [Pubmed]
  19. Expression of ST2 in helper T lymphocytes of malignant pleural effusions. Oshikawa, K., Yanagisawa, K., Ohno, S., Tominaga, S., Sugiyama, Y. Am. J. Respir. Crit. Care Med. (2002) [Pubmed]
  20. Establishment and characterization of a pancreatic carcinoma cell line derived from malignant pleural effusion. Starr, A.N., Vexler, A., Marmor, S., Konik, D., Ashkenasi-Voghera, M., Lev-Ari, S., Greif, Y., Ben-Yosef, R. Oncology (2005) [Pubmed]
  21. Increased coagulation activity of the pleura after tube drainage and quinacrine instillation in malignant pleural effusion. Agrenius, V., Chmielewska, J., Widström, O., Blombäck, M. Eur. Respir. J. (1991) [Pubmed]
  22. Lymphokine-activated killer induction and its regulation by macrophages in malignant pleural effusions. Yanagawa, H., Sone, S., Nii, A., Fukuta, K., Nakanishi, M., Maeda, K., Honda, M., Ogura, T. Jpn. J. Cancer Res. (1989) [Pubmed]
  23. T-helper type 1/T-helper type 2 balance in malignant pleural effusions compared to tuberculous pleural effusions. Okamoto, M., Hasegawa, Y., Hara, T., Hashimoto, N., Imaizumi, K., Shimokata, K., Kawabe, T. Chest (2005) [Pubmed]
  24. Evaluation of inflammatory cytokines in malignant and benign pleural effusions. Alexandrakis, M.G., Coulocheri, S.A., Bouros, D., Mandalaki, K., Karkavitsas, N., Eliopoulos, G.D. Oncol. Rep. (2000) [Pubmed]
  25. Interleukin (IL-)15 has less activity than IL-2 to promote type 2 cytokine predominance in tumour-associated mononuclear cells from lung cancer patients. Takeuchi, E., Yanagawa, H., Suzuki, Y., Shinkawa, K., Bando, H., Sone, S. Cytokine (2001) [Pubmed]
  26. Evaluation of interferon-gamma, interferon-gamma-inducing cytokines, and interferon-gamma-inducible chemokines in tuberculous pleural effusions. Okamoto, M., Kawabe, T., Iwasaki, Y., Hara, T., Hashimoto, N., Imaizumi, K., Hasegawa, Y., Shimokata, K. J. Lab. Clin. Med. (2005) [Pubmed]
  27. Characterization of a tumor necrosis factor-alpha inhibitor activity in cancer patients. Martinet, N., Charles, T., Vaillant, P., Vignaud, J.M., Lambert, J., Martinet, Y. Am. J. Respir. Cell Mol. Biol. (1992) [Pubmed]
  28. Interpretation of pleural biopsy specimens and aspirates with the immunoperoxidase technique. Herbert, A., Gallagher, P.J. Thorax (1982) [Pubmed]
  29. Intrapleural doxycycline control of malignant pleural effusions. Robinson, L.A., Fleming, W.H., Galbraith, T.A. Ann. Thorac. Surg. (1993) [Pubmed]
  30. Sclerotherapy for malignant pleural effusions: a prospective randomized trial of bleomycin vs doxycycline with small-bore catheter drainage. Patz, E.F., McAdams, H.P., Erasmus, J.J., Goodman, P.C., Culhane, D.K., Gilkeson, R.C., Herndon, J. Chest (1998) [Pubmed]
WikiGenes - Universities